Benefits
Sleep study in 21 adults, 800 mg nightly, no placebo group
Twenty-one Korean adults with poor sleep, mean age 55, took 800 mg of a 75 percent ethanol extract nightly for two weeks. On polysomnography, total sleep time rose from 327 to 357 minutes (p = 0.014) and time spent aroused during the night fell from 76 to 48 minutes (p = 0.009). There was no placebo group and no randomisation: every figure is a change against the person's own baseline, so it cannot be separated from natural night-to-night variation or from expecting to sleep better.
Poria plus Ziziphus plus GABA blend, 4-week trial in 70 adults
Seventy adults with sleep complaints took 10 mL a day of a liquid containing Poria cocos, Ziziphus spinosa and GABA, or a placebo, for four weeks. In the active group total sleep time rose 12.96 percent and the Pittsburgh Sleep Quality Index score fell 59.94 percent against their own baseline, and the active group also improved more than placebo on both measures. Two things limit what this says about Poria: GABA has a sleep literature of its own, and the study was designed, run and written by staff of the company that sells the product.
Anti-swelling triterpenes in mice (animal data only)
Nukaya 1996 (Chemical and Pharmaceutical Bulletin 44:847) isolated four lanostane triterpene acids from a methanol extract of Poria cocos and showed they reduced TPA-induced ear swelling in mice. That is the whole finding: isolated compounds, one animal model, one endpoint. Nobody has measured swelling, fluid balance or urine output in a person taking Poria by mouth.
Why the cancer research on Poria does not apply to a supplement
Poria turns up in hospital research on multi-herb prescription formulas given alongside paclitaxel and carboplatin chemotherapy, and in laboratory work on cultured cancer cells. That research is about supervised cancer care using prescription formulas, not about a supplement, and it says nothing about what a Poria capsule does. Poria is not a cancer treatment. Anyone in cancer care should not add it, and should tell their oncologist about everything they take.
Isolated triterpenes in cell culture (no human data)
Pachymic acid and polyporenic acid C are single triterpenes purified out of the sclerotium. Applied directly to cultured cells they change NF-kB signalling, MMP-9 expression and cell-death pathways. These are purified compounds applied straight to cells, at concentrations that have not been shown to occur in the blood of anyone swallowing Poria, and no outcome in a person has been measured. Nothing here means Poria affects cancer.
What is and is not established for Poria on its own
A PubMed search for Poria cocos, Wolfiporia, Fu Ling or Hoelen restricted to randomised and clinical trial publication types returns 21 records. Almost all of them test multi-herb formulas such as Xiaoyaosan, Keishi-bukuryo-gan or Sijunzi Tang, and nothing measured for a formula belongs to any one of its herbs. The single-herb human entries in that list did not involve swallowing Poria at all: two applied it to the skin in a cream (a 2006 German study on irritated skin and a 2018 study of skin tone) and a 2011 study in wrestlers added Poria polysaccharide to blood cells in a dish. For Poria swallowed on its own there is one uncontrolled 21-person sleep study. Memory, mood, anxiety, fatigue, immunity and fluid balance have not been measured in people taking Poria alone.
Mechanism of action
Triterpene anti-inflammatory and diuretic (Nukaya 1996)
Lanostane-type triterpene acids isolated from Poria reduced TPA-induced ear swelling in mice (Nukaya 1996). This is offered as the mechanism behind the traditional damp-draining use, but the animal work measured swelling, not urine output, and no diuretic effect has been measured in a person.
Pachymic acid NF-κB / MMP-9 suppression
In cultured cells, pachymic acid suppresses NF-kB signalling and MMP-9 expression (Ling and colleagues, Breast Cancer Research and Treatment 2011). This is cell-culture pharmacology of a purified compound and has not been shown to happen in a person who swallows Poria.
Polyporenic acid C in cell-culture apoptosis assays
Polyporenic acid C triggers caspase-8-dependent cell death in a cultured human lung cell line. That is a laboratory observation about a purified compound and carries no implication for anyone taking Poria.
Polysaccharide immunomodulation
Poria polysaccharides interact with beta-glucan receptors such as Dectin-1 in laboratory and animal immune models. No immune outcome has been measured in a person taking Poria by mouth.
Proposed GABAergic pathway behind the traditional calming use
A GABAergic pathway is proposed for the traditional calming use, but it remains a proposal rather than a demonstrated mechanism for Poria. The clearest sleep result on this page comes from a blend that contained GABA itself, so the pathway may belong to the GABA and not to the mushroom.
Liver and kidney findings in rodent injury models
Rat and mouse studies report lower liver and kidney injury markers after Poria extracts in chemically induced damage models, for example LPS and D-galactosamine liver injury and contrast-induced kidney injury. No liver or kidney outcome has been measured in a person taking Poria.
Clinical trials
Kim H, Choi H, Park BG, Ju HJ, Kim YI 2023 (Nutrients 15(19):4242). Single-arm, no placebo, no randomisation. 21 adults, 800 mg of a 75 percent ethanol extract nightly for two weeks.
21 adults with poor sleep, every one of them given the extract. There was no placebo group, no control arm and no randomisation.
Kim H, Choi H, Park BG, Ju HJ, Kim YI 2023 (Nutrients 15(19):4242). Single-arm, no placebo, no randomisation. 21 adults, 800 mg of a 75 percent ethanol extract nightly for two weeks. Total sleep time rose from 327 to 357 minutes and time aroused during the night fell from 76 to 48 minutes on polysomnography (p = 0.014 and p = 0.009 against each person's own baseline). With no placebo group, the change cannot be separated from natural variation or from expecting to sleep better.
Hao Y, Song W, Qu L 2024 (Food Science and Nutrition 12(6):3883-3892, PMID 38873452). All three authors are employed by Yunnan Botanee Bio-technology Group and its subsidiaries, which make the product tested.
70 adults with sleep complaints, randomised to the Poria plus Ziziphus plus GABA liquid or to placebo.
Hao Y, Song W, Qu L 2024 (Food Science and Nutrition 12(6):3883-3892, PMID 38873452). All three authors are employed by Yunnan Botanee Bio-technology Group and its subsidiaries, which make the product tested. Seventy adults with sleep complaints took 10 mL a day of a Poria cocos, Ziziphus spinosa and GABA liquid, or placebo, for four weeks. Total sleep time rose 12.96 percent and the PSQI score fell 59.94 percent against the active group's own baseline, and the active group also improved more than placebo on both. The trial also measured skin hydration and wrinkles. GABA has a sleep literature of its own, so nothing here can be assigned to Poria.
Peng X, Jia C, Chi H, Wang P, Fu H, Li Y, Wang Q 2022 (Frontiers in Pharmacology 13:788810, PMID 35401186). A systematic review plus network pharmacology and cell experiments, not a trial.
922 patients with ovarian cancer receiving paclitaxel and carboplatin in 13 randomised trials
Peng X, Jia C, Chi H, Wang P, Fu H, Li Y, Wang Q 2022 (Frontiers in Pharmacology 13:788810, PMID 35401186). A systematic review plus network pharmacology and cell experiments, not a trial. A pooled analysis of 13 randomised trials (922 patients) in which prescription multi-herb formulas containing Poria were given alongside paclitaxel and carboplatin for ovarian cancer, followed by computational and cell experiments. This is oncology research on prescribed formulas under medical supervision. It is not evidence about a Poria supplement, and Poria is not a treatment for cancer.